BRIEF published on 11/03/2025 at 09:06, 1 month 12 days ago Innoscripta SE Achieves Robust Growth in Q3 2025 Revenue Growth Q3 2025 Results Innoscripta SE R&D Tax Incentives Digital Optimization
PRESS RELEASE published on 11/03/2025 at 09:01, 1 month 12 days ago innoscripta reports successful third quarter of 2025 innoscripta SE reports strong financial performance in Q3 2025 with significant revenue and EBIT growth. The company attributes success to digital process optimization and platform development Revenue Growth Financial Performance Q3 2025 Innoscripta SE Digital Processes
BRIEF published on 10/29/2025 at 17:36, 1 month 16 days ago Innoscripta SE to Release Q3 2025 Financial Results Investors Financial Performance Transparency Third-quarter Results Innoscripta SE
PRESS RELEASE published on 10/29/2025 at 17:31, 1 month 16 days ago innoscripta SE announces publication of Q3 figures for 2025 innoscripta SE to release Q3 2025 financial results on November 3, 2025, providing insights into the Company's performance and key figures Financial Results Company Performance Key Figures Q3 2025 Innoscripta SE
BRIEF published on 08/21/2025 at 08:00, 3 months 25 days ago Innoscripta SE Reports Strong Growth in First Half of 2025 Software Solutions Financial Growth Innoscripta SE R&D Tax Incentives Clusterix Platform
PRESS RELEASE published on 08/21/2025 at 07:55, 3 months 25 days ago innoscripta reports successful first half of 2025 innoscripta SE reports successful first half of 2025 with significant revenue and net income growth, driven by digital process optimization and platform development Revenue Growth First Half Results Innoscripta SE Digital Processes R&D Incentives
BRIEF published on 08/06/2025 at 11:38, 4 months 9 days ago Innoscripta SE Set to Release Mid-Year Financials for 2025 Half-year Report Munich Online Meeting 2025 Financials Innoscripta SE
PRESS RELEASE published on 08/06/2025 at 11:33, 4 months 9 days ago innoscripta SE announces publication of half-year figures for 2025 innoscripta SE announces publication of half-year figures for 2025 providing insights on operational, financial development, and strategic progress. Online meeting scheduled to discuss results on August 21, 2025 Financial Development Online Meeting Half-Year Figures 2025 Fiscal Year Innoscripta SE
BRIEF published on 06/17/2025 at 13:18, 5 months 28 days ago Innoscripta SE Founders Plan Strategic Share Purchases Market Strategy Share Purchase Innoscripta SE Founders' Confidence R&D Software
PRESS RELEASE published on 06/17/2025 at 13:13, 5 months 28 days ago innoscripta SE: Founders Plan Selective Share Purchases to Support Share Price innoscripta SE founders plan selective share purchases to support share price, demonstrating long-term confidence in business model. Shares subject to lock-up obligations Share Purchases Founders Innoscripta SE Share Price Support Long-term Confidence
Published on 12/15/2025 at 16:35, 27 minutes ago Stillwater Critical Minerals Announces Upsize of Bought Deal LIFE Private Placement for Gross Proceeds of C$15 Million
Published on 12/15/2025 at 15:00, 2 hours 2 minutes ago Kingfisher Reports Annual General Meeting Voting Results
Published on 12/15/2025 at 15:00, 2 hours 2 minutes ago Jaguar Health Announces Abstract Submission for Preliminary Data from US Investigator-Initiated Trial of Crofelemer in Adult Patients with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
Published on 12/15/2025 at 14:30, 2 hours 32 minutes ago Unusual Machines Congratulates Customers Selected for the Army's PBAS Tranche 1.1, Including Envision Technology and Strategic Logix
Published on 12/15/2025 at 14:00, 3 hours 2 minutes ago Dateline Delivers Further High-Grade Intercepts from North Pipe at Colosseum
Published on 12/15/2025 at 16:42, 20 minutes ago EQS-Adhoc: Vitruvia Medical AG: successfull capital increase and strengthening of the financial structure
Published on 12/15/2025 at 16:08, 54 minutes ago Conversion of The Platform Group AG into a KGaA completed as planned
Published on 12/15/2025 at 15:50, 1 hour 12 minutes ago Original-Research: Cabka N.V. (von First Berlin Equity Research GmbH): Kaufen
Published on 12/15/2025 at 15:49, 1 hour 13 minutes ago Mutares submits an irrevocable offer to acquire Venator Ultramarine Blue Pigments business from Venator France SAS
Published on 12/15/2025 at 15:45, 1 hour 17 minutes ago Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated
Published on 12/15/2025 at 11:50, 5 hours 12 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of November 30, 2025
Published on 12/12/2025 at 18:00, 2 days 23 hours ago Disclosure of trading in own shares between November 24th and November 28th, 2025
Published on 12/11/2025 at 08:30, 4 days 8 hours ago Edenred and Daimler Truck join forces to accelerate the rollout of charging infrastructure for electric trucks in Europe
